A Study of Belantamab Mafodotin Monotherapy in Multiple Myeloma Participants With Normal and Varying Degree of Impaired Renal Function
Clinical trial NCT04398745 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04398745
- Sponsor
- GlaxoSmithKline
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-09
- Primary completion
- 2025-04-21
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.